Table 1 Association of RBM38 with c-Myc and clinicopathological characteristics of breast cancer
From: The role of c-Myc-RBM38 loop in the growth suppression in breast cancer
Clinicopathological characteristics | RBM38 expression | |||
|---|---|---|---|---|
Cases (n) | Low (%) | High (%) | P-value | |
Age (years) | 0.196 | |||
<50 | 66 | 31 (46.7) | 35 (53.3) | Â |
≥50 | 96 | 55 (57.3) | 41 (42.7) |  |
Tumor size | 0.629 | |||
≤2 cm | 65 | 33 (50.8) | 32 (49.2) |  |
˃2 cm | 97 | 53 (54.6) | 44 (45.4) |  |
TNM stage | 0.127 | |||
I–II | 128 | 64 (63.4) | 64 (36.6) |  |
III | 34 | 22 (87.5) | 12 (12.5) | Â |
c-Myc | 0.014 | |||
Low | 108 | 50 (46.3) | 58 (53.7) | Â |
High | 54 | 36 (66.7) | 18 (33.3) | Â |